Sam Altman-backed AI biotech announces $1 billion for its lofty goal: adding 10 years to human life span

Rate this post




Retro Biosciences will return to clinical trials of three drugs, including this year’s research, including potential treatment of Alzheimer’s disease. Read more:

 
Report

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *